Publication | Open Access
Discovery and preclinical profile of LX-039, a novel indole-based oral selective estrogen receptor degrader (SERD)
16
Citations
6
References
2022
Year
MedicineDrug DiscoveryHormonal ReceptorAromatasePreclinical ProfileEndocrinologyPharmacologyEndocrine-related CancerBiomolecular Engineering
| Year | Citations | |
|---|---|---|
Page 1
Page 1